← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. ILMN
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

ILMN logoIllumina, Inc. (ILMN) P/E Ratio History

Historical price-to-earnings valuation from 2006 to 2026

Current P/E
25.5
Undervalued
5Y Avg P/E
56.3
-55% vs avg
PE Percentile
20%
Below Avg
PEG Ratio
6.01
Expensive
TTM EPS$5.54
Price$138.71
5Y PE Range12.0 - 88.4
Earnings Yield3.93%

Loading P/E history...

ILMN Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
25.5vs56.3
-55%
Cheap vs History
vs. Healthcare
25.5vs22.3
+14%
Above Sector
vs. S&P 500
25.5vs25.1
+1%
In Line with Market
PEG Analysis
6.01
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 171% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 10, 2026, Illumina, Inc. (ILMN) trades at a price-to-earnings ratio of 25.5x, with a stock price of $138.71 and trailing twelve-month earnings per share of $5.54.

The current P/E is 55% below its 5-year average of 56.3x. Over the past five years, ILMN's P/E has ranged from a low of 12.0x to a high of 88.4x, placing the current valuation at the 20th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, ILMN is roughly in line with its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

The PEG ratio of 6.01 (P/E divided by 171% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, ILMN trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ILMN DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ILMN P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
TMO logoTMOThermo Fisher Scientific Inc.
$176B26.812.67+7%
DHR logoDHRDanaher Corporation
$124B34.9--5%
A logoAAgilent Technologies, Inc.
$34B26.01.76Best+3%
BIO logoBIOBio-Rad Laboratories, Inc.
$7B9.2Lowest-+143%Best

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

ILMN Historical P/E Data (2006–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1Sun Mar 29 2026 00:00:00 GM$117.67$5.5121.4x-70%
FY2025 Q4Sun Dec 28 2025 00:00:00 GM$134.95$5.4624.7x-66%
FY2025 Q3Sun Sep 28 2025 00:00:00 GM$91.69$4.4620.6x-71%
FY2025 Q2Sun Jun 29 2025 00:00:00 GM$94.79$7.9012.0x-83%
FY2022 Q1Sun Apr 03 2022 00:00:00 GM$353.65$4.5877.2x+7%
FY2021 Q4Fri Dec 31 2021 00:00:00 GM$369.72$5.0473.4x+2%
FY2021 Q3Sun Oct 03 2021 00:00:00 GM$383.72$6.0863.1x-12%
FY2021 Q2Sun Jul 04 2021 00:00:00 GM$461.36$5.2288.4x+23%
FY2021 Q1Sun Apr 04 2021 00:00:00 GM$374.19$4.2887.5x+21%
FY2020 Q4$359.58$4.4580.8x+12%
FY2020 Q3Sun Sep 27 2020 00:00:00 GM$291.44$4.3167.5x-6%
FY2020 Q2Sun Jun 28 2020 00:00:00 GM$349.94$4.6874.7x+4%

Average P/E for displayed period: 72.1x

Full ILMN Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See ILMN's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ILMN Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ILMN vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ILMN — Frequently Asked Questions

Quick answers to the most common questions about buying ILMN stock.

Is ILMN stock overvalued or undervalued?

ILMN trades at 25.5x P/E, below its 5-year average of 56.3x. At the 20th percentile of historical range, the stock is priced at a discount to its own history.

How does ILMN's valuation compare to peers?

Illumina, Inc. P/E of 25.5x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is ILMN's PEG ratio?

ILMN PEG ratio is 6.01. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2006-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ILMN P/E Ratio History (2006–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.